| Entry |
|
|---|
| Name |
|
|---|
| Definition |
KSHV macrophage inflammatory protein 2
|
|---|
| Pathway |
| ko04061 | Viral protein interaction with cytokine and cytokine receptor |
| ko05167 | Kaposi sarcoma-associated herpesvirus infection |
|
|---|
| Brite |
KEGG Orthology (KO) [BR:ko00001]
09130 Environmental Information Processing
09133 Signaling molecules and interaction
04061 Viral protein interaction with cytokine and cytokine receptor
K21657 K4; KSHV macrophage inflammatory protein 2
09160 Human Diseases
09161 Cancer: overview
05203 Viral carcinogenesis
K21657 K4; KSHV macrophage inflammatory protein 2
09172 Infectious disease: viral
05167 Kaposi sarcoma-associated herpesvirus infection
K21657 K4; KSHV macrophage inflammatory protein 2
09180 Brite Hierarchies
09183 Protein families: signaling and cellular processes
03200 Viral proteins
K21657 K4; KSHV macrophage inflammatory protein 2
Viral proteins [BR:ko03200]
dsDNA viruses
Kaposi's sarcoma-associated herpesvirus (Human herpesvirus 8)
K21657 K4; KSHV macrophage inflammatory protein 2
|
|---|
| Genes |
|
|---|
| Reference |
|
|---|
| Authors |
Luttichau HR, Johnsen AH, Jurlander J, Rosenkilde MM, Schwartz TW |
|---|
| Title |
Kaposi sarcoma-associated herpes virus targets the lymphotactin receptor with both a broad spectrum antagonist vCCL2 and a highly selective and potent agonist vCCL3. |
|---|
| Journal |
|
|---|
| Sequence |
|
|---|
| LinkDB |
|
|---|
